Supreme Petrochem Ltd Q4 FY26 Earnings Analysis

Published 15 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹13.3K Cr

Price

727

Market Cap

₹13.3K Cr

P/E Ratio

27.1

Earnings Summary

The company expects an 8% to 10% volume growth in FY27, contingent on global market normalization by June-July 2026. The company anticipates volume growth of 8-10% for the year if global conditions, including war impacts, normalize by June-July 2026.

📊 Revenue & Sales Performance

  • The company expects an 8% to 10% volume growth in FY27, contingent on global market normalization by June-July 2026.
  • With ABS operational, overall volume growth aligns with market growth; however, Q1 FY27 might see lower growth due to ongoing global uncertainties.
  • The ABS plant currently operates at around 65-70% capacity with expectations to reach 80-90% utilization in FY27.
  • Phase two expansion of ABS is underway, independent of equipment issues, indicating future capacity increase.
  • The EPS Phase-II expansion was successfully commissioned in April 2026, increasing capacity from 85,000 to 115,000 tons per annum.
  • The company plans to continue volume growth in compounding divisions and production, aiming to reach 50,000 tons in SPC and Xmold divisions by FY28.
  • Operating EBITDA is expected to improve if the market situation normalizes post Q1 FY27.

📈 Profitability & Margins

  • The company anticipates volume growth of 8-10% for the year if global conditions, including war impacts, normalize by June-July 2026.
  • EBITDA for FY27 is expected to be maintained at least at FY26 levels or potentially improve if market conditions normalize.
  • Operating cash flow may stabilize with a sustainable receivable cycle of 30-35 days following normalization of prices and material supply.
  • Expansion projects like EPS Phase-II and ABS Phase-II are progressing, expected to contribute to volume and earnings growth by FY27-FY28.
  • The company is focused on growing volumes alongside market growth and expects improved spreads and volumes once supply chain issues ease.
  • No specific EPS guidance was given, but improved volumes, better margins, and operational efficiencies hint at potential earnings growth.

🏗️ Capital Expenditure Plans

- EPS Phase-II expansion at Nagothane commissioned in April 2026, increasing capacity from 85,000 to 115,000 tons per annum. - ABS mass plant restarted with modified arrangements, currently operating at ~65% capacity; aiming to reach 80-90% utilization in FY27. - Phase-II ABS expansion planned for FY28; work progressing irrespective of current equipment issues. - Haryana CAPEX for FY27 is limited to infrastructure and related activities due to delayed IOC styrene monomer plant; major spending on PS and EPS pending clearer commissioning timeline. - Company-wide CAPEX guidance for FY27 is approximately INR 250 crores, funded entirely through internal accruals. - Future de-bottlenecking of polystyrene capacity under evaluation; timeline not yet finalized. Overall, Supreme Petrochem is focusing on capacity expansion in EPS and ABS, cautious Haryana investments, and internal funding for capex.

💰 Fundraising & Capital Structure

  • Supreme Petrochem Limited remains debt-free as of March 2026.
  • The company has an investable surplus of INR 700 crores.
  • All capital expenditures are funded through internal accruals.
  • There is no mention of any current or planned fundraising through debt or equity.
  • The company is cautious with CAPEX, especially in Haryana, linked to upstream project timelines.
  • Overall, no new external fundraising through debt or equity is indicated in the report.

📋 Order Book & Pipeline

  • The transcript does not provide specific numerical details on the current or expected order book or pending orders for Supreme Petrochem Limited.
  • Discussions indicate ongoing demand and operations, with certain capacity utilizations (e.g., ABS plant at 65% of design capacity) and production volumes mentioned, but order backlog specifics are not disclosed.
  • Growth expectations are based on volume increases aligned with market growth (8-10% volume growth guidance mentioned).
  • Demand scenarios vary between OEM and non-OEM segments, with roughly a 50-50 split anticipated for some products.
  • External factors such as geopolitical situations and raw material supply constraints influence operational performance and market supply.
  • No explicit mention of order book size or pending orders in the available text.

Key Metrics

Frequently Asked Questions

What were Supreme Petrochem Ltd Q4 FY26 results?

The company expects an 8% to 10% volume growth in FY27, contingent on global market normalization by June-July 2026. The company anticipates volume growth of 8-10% for the year if global conditions, including war impacts, normalize by June-July 2026.

What is Supreme Petrochem Ltd share price analysis?

Supreme Petrochem Ltd currently shows a neutral. The stock trades at a P/E of 27.1 with a market cap of ₹13,276 Cr. Investors should review the full earnings analysis for detailed insights.

Is Supreme Petrochem Ltd planning capital expenditure?

EPS Phase-II expansion at Nagothane commissioned in April 2026, increasing capacity from 85,000 to 115,000 tons per annum.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

What Supreme Petrochem Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season